+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Genome Editing/Genome Engineering - Market Analysis, Trends, and Forecasts

  • ID: 4805049
  • Report
  • 110 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Crispr Therapeutics Ag
  • Editas Medicine
  • Lonza Group Ag
  • Merck & Co.
  • New England Biolabs
  • Origene Technologies
  • MORE
Genome Editing/Genome Engineering market worldwide is projected to grow by US$5.8 Billion, driven by a compounded growth of 14.8%. CRISPR, one of the segments analyzed and sized in this study, displays the potential to grow at over 15.7%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$3.9 Billion by the year 2025, CRISPR will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 15.9% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$225.1 Million to the region's size and clout in the next 5 to 6 years. Over US$278.6 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, CRISPR will reach a market size of US$318.1 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 14.5% over the next couple of years and add approximately US$1 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • CRISPR Therapeutics AG
  • Editas Medicine, Inc.
  • GenScript Biotech Corporation
  • Horizon Discovery Group PLC
  • Integrated DNA Technologies (IDT), Inc.
  • Lonza Group AG
  • Merck & Co., Inc.
  • New England Biolabs, Inc.
  • OriGene Technologies, Inc.
  • Sangamo Therapeutics
  • Thermo Fisher Scientific, Inc.
  • Transposagen Biopharmaceuticals, Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Crispr Therapeutics Ag
  • Editas Medicine
  • Lonza Group Ag
  • Merck & Co.
  • New England Biolabs
  • Origene Technologies
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Genome Editing/Genome Engineering Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Genome Editing/Genome Engineering Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Genome Editing/Genome Engineering Market Share Shift across Key Geographies Worldwide: 2019 VS 2025

TABLE 3: CRISPR (Technology) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 4: CRISPR (Technology) Market Share Breakdown of Worldwide Sales by Region/Country: 2019 VS 2025

TABLE 5: TALEN (Technology) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 6: TALEN (Technology) Market Sales Breakdown by Region/Country in Percentage: 2019 VS 2025

TABLE 7: ZFN (Technology) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 8: ZFN (Technology) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025

TABLE 9: Other Technologies (Technology) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 10: Other Technologies (Technology) Market Share Breakdown by Region/Country: 2019 VS 2025

TABLE 11: Cell Line Engineering (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 12: Cell Line Engineering (Application) Distribution of Global Sales by Region/Country: 2019 VS 2025

TABLE 13: Animal Genetic Engineering (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025

TABLE 14: Animal Genetic Engineering (Application) Global Market Share Distribution by Region/Country for 2019 and 2025

TABLE 15: Plant Genetic Engineering (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025

TABLE 16: Plant Genetic Engineering (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2019 VS 2025

TABLE 17: Other Applications (Application) Worldwide Sales in US$ Million by Region/Country: 2018-2025

TABLE 18: Other Applications (Application) Market Share Shift across Key Geographies: 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Genome Editing/Genome Engineering Market Share (in %) by Company: 2019 & 2025

TABLE 19: Genome Editing/Genome Engineering Market in US$ Million in the United States by Technology: 2018-2025

TABLE 20: United States Genome Editing/Genome Engineering Market Share Breakdown by Technology: 2019 VS 2025

TABLE 21: United States Genome Editing/Genome Engineering Latent Demand Forecasts in US$ Million by Application: 2018 to 2025

TABLE 22: Genome Editing/Genome Engineering Market Share Breakdown in the United States by Application: 2019 VS 2025

CANADA

TABLE 23: Genome Editing/Genome Engineering Market Analysis in Canada in US$ Million by Technology: 2018-2025

TABLE 24: Canadian Genome Editing/Genome Engineering Market Share Breakdown by Technology: 2019 VS 2025

TABLE 25: Canadian Genome Editing/Genome Engineering Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025

TABLE 26: Canadian Genome Editing/Genome Engineering Market Share Analysis by Application: 2019 VS 2025

JAPAN

TABLE 27: Japanese Medium & Long-Term Outlook for Genome Editing/Genome Engineering Market in US$ Million by Technology: 2018-2025

TABLE 28: Japanese Genome Editing/Genome Engineering Market Percentage Share Distribution by Technology: 2019 VS 2025

TABLE 29: Japanese Demand Estimates and Forecasts for Genome Editing/Genome Engineering in US$ Million by Application: 2018 to 2025

TABLE 30: Genome Editing/Genome Engineering Market Share Shift in Japan by Application: 2019 VS 2025

CHINA

TABLE 31: Genome Editing/Genome Engineering Market Estimates and Forecasts in China in US$ Million by Technology: 2018-2025

TABLE 32: Genome Editing/Genome Engineering Market in China: Percentage Share Analysis by Technology for 2019 and 2025

TABLE 33: Chinese Demand for Genome Editing/Genome Engineering in US$ Million by Application: 2018 to 2025

TABLE 34: Chinese Genome Editing/Genome Engineering Market Share Breakdown by Application: 2019 VS 2025

EUROPE

Market Facts & Figures

European Genome Editing/Genome Engineering Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 35: European Genome Editing/Genome Engineering Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 36: European Genome Editing/Genome Engineering Market Share Shift by Region/Country: 2019 VS 2025

TABLE 37: European Genome Editing/Genome Engineering Market Assessment in US$ Million by Technology: 2018-2025

TABLE 38: Genome Editing/Genome Engineering Market in Europe: Percentage Breakdown of Sales by Technology for 2019 and 2025

TABLE 39: European Genome Editing/Genome Engineering Addressable Market Opportunity in US$ Million by Application: 2018-2025

TABLE 40: European Genome Editing/Genome Engineering Market Share Analysis by Application: 2019 VS 2025

FRANCE

TABLE 41: French Genome Editing/Genome Engineering Market Estimates and Projections in US$ Million by Technology: 2018-2025

TABLE 42: French Genome Editing/Genome Engineering Market Share Breakdown by Technology: 2019 VS 2025

TABLE 43: Genome Editing/Genome Engineering Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025

TABLE 44: French Genome Editing/Genome Engineering Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025

GERMANY

TABLE 45: German Genome Editing/Genome Engineering Latent Demand Forecasts in US$ Million by Technology: 2018-2025

TABLE 46: German Genome Editing/Genome Engineering Market Share Breakdown by Technology: 2019 VS 2025

TABLE 47: Genome Editing/Genome Engineering Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025

TABLE 48: Genome Editing/Genome Engineering Market Share Distribution in Germany by Application: 2019 VS 2025

ITALY

TABLE 49: Genome Editing/Genome Engineering Market Estimates and Forecasts in Italy in US$ Million by Technology: 2018-2025

TABLE 50: Genome Editing/Genome Engineering Market in Italy: Percentage Share Analysis by Technology for 2019 and 2025

TABLE 51: Italian Demand for Genome Editing/Genome Engineering in US$ Million by Application: 2018 to 2025

TABLE 52: Italian Genome Editing/Genome Engineering Market Share Breakdown by Application: 2019 VS 2025

UNITED KINGDOM

TABLE 53: United Kingdom Medium & Long-Term Outlook for Genome Editing/Genome Engineering Market in US$ Million by Technology: 2018-2025

TABLE 54: United Kingdom Genome Editing/Genome Engineering Market Percentage Share Distribution by Technology: 2019 VS 2025

TABLE 55: United Kingdom Demand Estimates and Forecasts for Genome Editing/Genome Engineering in US$ Million by Application: 2018 to 2025

TABLE 56: Genome Editing/Genome Engineering Market Share Shift in the United Kingdom by Application: 2019 VS 2025

REST OF EUROPE

TABLE 57: Rest of Europe Genome Editing/Genome Engineering Market Assessment in US$ Million by Technology: 2018-2025

TABLE 58: Genome Editing/Genome Engineering Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2019 and 2025

TABLE 59: Rest of Europe Genome Editing/Genome Engineering Addressable Market Opportunity in US$ Million by Application: 2018-2025

TABLE 60: Rest of Europe Genome Editing/Genome Engineering Market Share Analysis by Application: 2019 VS 2025

ASIA-PACIFIC

TABLE 61: Asia-Pacific Genome Editing/Genome Engineering Market Estimates and Projections in US$ Million by Technology: 2018-2025

TABLE 62: Asia-Pacific Genome Editing/Genome Engineering Market Share Breakdown by Technology: 2019 VS 2025

TABLE 63: Genome Editing/Genome Engineering Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025

TABLE 64: Asia-Pacific Genome Editing/Genome Engineering Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025

REST OF WORLD

TABLE 65: Genome Editing/Genome Engineering Market Analysis in Rest of World in US$ Million by Technology: 2018-2025

TABLE 66: Rest of World Genome Editing/Genome Engineering Market Share Breakdown by Technology: 2019 VS 2025

TABLE 67: Rest of World Genome Editing/Genome Engineering Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025

TABLE 68: Rest of World Genome Editing/Genome Engineering Market Share Analysis by Application: 2019 VS 2025

IV. COMPETITION

CRISPR THERAPEUTICS AG

EDITAS MEDICINE

GENSCRIPT BIOTECH CORPORATION

HORIZON DISCOVERY GROUP PLC

INTEGRATED DNA TECHNOLOGIES (IDT), INC.

LONZA GROUP AG

MERCK & CO.

NEW ENGLAND BIOLABS

ORIGENE TECHNOLOGIES

SANGAMO THERAPEUTICS

THERMO FISHER SCIENTIFIC

TRANSPOSAGEN BIOPHARMACEUTICALS

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Crispr Therapeutics Ag
  • Editas Medicine
  • Genscript Biotech Corporation
  • Horizon Discovery Group Plc
  • Integrated Dna Technologies (Idt), Inc.
  • Lonza Group Ag
  • Merck & Co.
  • New England Biolabs
  • Origene Technologies
  • Sangamo Therapeutics
  • Thermo Fisher Scientific
  • Transposagen Biopharmaceuticals
Note: Product cover images may vary from those shown
Adroll
adroll